Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus

Published:2020-11-19 Issue:11 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ipsen Emil Ørskov¹,Madsen Kasper S¹,Chi Yuan²,Pedersen-Bjergaard Ulrik³,Richter Bernd⁴,Metzendorf Maria-Inti⁴,Hemmingsen Bianca⁴

Affiliation:

1. Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

2. Centre for Evidence-Based Chinese Medicine; Beijing University of Chinese Medicine; Beijing China

3. Department of Cardiology, Nephrology and Endocrinology; Nordsjaellands Hospital; Hillerød Denmark

4. Cochrane Metabolic and Endocrine Disorders Group; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference204 articles.

1. Increase in serum fibroblast growth factor-21 (FGF-21) predicts development of diabetes in IGT subjects and pioglitazone attenuates the increase in FGF-21 and reduces conversion of IGT to T2DM;Alonzo;Diabetes,2016

2. Pioglitazone reduces the risk of converting impaired glucose tolerance to type 2 diabetes;Australian Journal of Pharmacy,2011

3. Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial;Bray;Diabetes, Obesity & Metabolism,2013

4. Actos now for the prevention of diabetes (ACT NOW) study;Defronzo;BMC Endocrine Disorders,2009

5. The disposition index does not reflect beta-cell function in IGT subjects treated with pioglitazone;Defronzo;Journal of Clinical Endocrinology and Metabolism,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-diabetic and diabetic adults;American Journal of Physiology-Endocrinology and Metabolism;2023-10-01

2. Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice;Experimental and Clinical Endocrinology & Diabetes;2023-09-20

3. Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study;Diabetes, Metabolic Syndrome and Obesity;2023-09

4. TorS ‐ Reframing a rational for type 2 diabetes treatment;Diabetes/Metabolism Research and Reviews;2023-08-24

5. A multicentric, randomized, controlled trial of yoga and fenugreek in prevention of type 2 diabetes mellitus: methodological details—the Indian Prevention of Diabetes Study (IPDS);International Journal of Diabetes in Developing Countries;2023-02-28